Article

Immunotherapy in Bladder Cancer: A Systematic Review of Clinical Trials and Therapeutic Advances

2025-10-08

Abstract excerpt

<title>Abstract</title> <p>Background: Bladder cancer poses significant morbidity, mortality, and healthcare burdens globally. While non-muscle-invasive bladder cancer (NMIBC) often initially responds to intravesical Bacillus Calmette-Guérin (BCG), many patients become unresponsive to BCG, resulting in recurrence or progression. Emerging immunotherapies, including checkpoint inhibitors (Pembrolizumab, Atezolizuma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c43dca79-828c-5e9d-be32-d1dd246f0267
DOI: 10.21203/rs.3.rs-6457129/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immunotherapy in Bladder Cancer: A Systematic Review of Clinical Trials and Therapeutic AdvancesDOI 10.21203/rs.3.rs-6457129/v1Read

Bladder Cancer: A Review.Semantic proximity Read

A Muscle-Invasive Bladder Cancer Patient With High Tumor Mutational Burden and RB1 Mutation Achieved Bladder Preservation Following Chemotherapy Combined With Immunotherapy: A Case Report.Semantic proximity Read

Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing.Semantic proximity Read

Oncolytic Virotherapy Combined with Nivolumab Elicits Complete Responses in Muscle-Invasive Bladder Cancer in Association with the Formation of Tertiary Lymphoid StructuresSemantic proximity Read

The Potential Antitumor Effects of Combining Intravesical Therapy with Recombinant Bacillus Calmette-Guérin and an Immune Checkpoint Inhibitor in Bladder CancerSemantic proximity Read

Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current DevelopmentSemantic proximity Read

Comparison of intravesical instillation of Bacille Calmette-Guérin and epirubicin: a randomized controlled trialSemantic proximity Read

Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study.Semantic proximity Read

New and promising strategies in the management of bladder cancer.Semantic proximity Read

Molecular targets and targeted therapies in bladder cancer managementSemantic proximity Read

The urothelial transcriptomic response to interferon gamma predicts T1 recurrence-free and basal/squamous muscle-invasive bladder cancer survival and better targeted strategies for immune checkpoint blockingSemantic proximity Read

Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.Semantic proximity Read